Experimental Treatments for Leptomeningeal Metastases from Solid Malignancies
Document Type
Article
Publication Date
2017
Abstract
Background: Leptomeningeal metastasis is a consequence of advanced solid malignancies and has limited treatment options. It is possible that it is becoming more common as the leptomeninges act as a sanctuary site for recurrence from systemic cancer. Methods: Potential targeted and immunotherapy agents for the most common types of solid-tumor leptomeningeal metastasis are reviewed, as are their dosing/delivery strategies and novel, immunological approaches. Results: Historically, patients with leptomeningeal metastasis have been excluded from clinical trials, and data on the management of leptomeningeal metastasis come from single case reports and retrospective analyses. Conclusion: For the first time ever, published reports suggest the tide may be turning in this challenging disease.
Digital Object Identifier (DOI)
https://doi.org/10.1177/107327481702400106
Citation / Publisher Attribution
Cancer Control, v. 24, issue 1, p. 42-46
Scholar Commons Citation
Sahebjam, Solmaz; Forsyth, Peter A.; Smalley, Keiran S.; and Tran, Nam D., "Experimental Treatments for Leptomeningeal Metastases from Solid Malignancies" (2017). Oncologic Sciences Faculty Publications. 4.
https://digitalcommons.usf.edu/onc_facpub/4
